Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects

Published:2022-03-02 Issue:8 Volume:11 Page:938-948
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Asari Kazuhiko¹,Ishii Mikio¹,Yoshitsugu Hiroyuki¹,Wakana Akira¹,Fancourt Craig²,Yoon Esther³,Furihata Kenichi⁴,McCrea Jacqueline B.²,Stoch S. Aubrey²,Iwamoto Marian²

Affiliation:

1. MSD K.K. Tokyo Japan

2. Merck & Co., Inc. Kenilworth New Jersey USA

3. PAREXEL International Early Phase Research Physicians Glendale California USA

4. P‐One Clinic Keikokai Medical Corporation Tokyo Japan

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1081

Reference33 articles.

1. Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation

2. Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

3. Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients

4. Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future

5. The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment;Viruses;2024-09-07

2. Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation;Clinical Pharmacokinetics;2024-07

3. Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study;Clinical and Experimental Nephrology;2024-04-13

4. A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing;Frontiers in Immunology;2024-02-01

5. Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity;Journal of Clinical Immunology;2023-12-20